Skip to main content Accessibility help
×
Home

Neuropsychiatrie of biologische psychiatrie; een toekomstvisie in historisch perspectief

  • W.M.A. Verhoeven (a1) and S. Tuinier (a2)

Summary

Neuropsychiatry or Biological Psychiatry There is an urgent need to reconsider the position of psychiatry within the neurosciences because of the exploding knowledge about the relationship between brain and behaviour and the delay in implementation of new findings due to the separation of neurology and psychiatry. Biological psychiatry and psychopharmacology originate from the discovery by chance of psycho-active compounds in the early fifties and have contributed to the scientification of psychiatry. The impact of biological psychiatry for the pathophysiology of psychiatric disorders, however, is limited as a result of its biased orientation on neurotransmitters and receptors. The neuropsychiatric paradigm integrates knowledge from several domains, such as functional neuroanatomy, genetics and endocrinology and opens new vistas for the involvement of neuronal circuits in the initiation and maintenance of behavioural disturbances. In addition, novel and more specific treatment modalities may emerge.

Copyright

Corresponding author

zenuwarts, Vincent van Gogh Instituut voor Psychiatrie, Stationsweg 46, 5803 AC Venray

References

Hide All
1.Trimble, MR. Neuropsychiatry or behavioral neurology. Neurop-sychiat, Neuropsychol Behav Neurol 1993;6;60–9.
2.Godderis, J. Galenos van Pergamon over psychische stoornissen: een bijdrage tot de geschiedenis van de begripsontwikkeling in de psychiatrie. Leuven/Amersfoort: Acco, 1988.
3.Von Bingen, H. Ursachen und Behandlung der Krankheiten. München: Hugo Schulz, 1933.
4.Diethelm, O. Medical Dissertations of psychiatrie Interest: printed before 1750. Basel: Karger, 1971.
5.Neugebauer, R. Treatment of the mentally ill in medieval and early modern England: a reappraisal. J Hist behav Sci 1978;14;158–69.
6.Trevisa, J. On the Properties of Things. Oxford: Clarendon Press, 1998.
7.Manzoni, T. The cerebral ventricles, the animal spirits and the dawn of brain localization of function. Arch Ital Biol 1998;136;103–52.
8.Hill, D. The bridge between neurology and psychiatry. Lancet 1964-1; 18: 509–14.
9.Lishman, WA. Neurologists and psychiatrists. In: The bridge between neurology and psychiatry. Reynolds, EH, Trimble, MR, eds. Edinburgh: Churchill Livingstone 1989; 2437.
10.Benson, DF. Neuropsychiatry and behavioural neurology: past, present, and future. J Neuropsychiat 1996;8;351–7.
11.Verhey, FHM. Acta Neuropsychiatrica; Tijdschrift voor een he-dendaagse neuropsychiatrie. Acta Neuropsychiat 1989;1;38.
12.Schroeder van der Kolk, JLC. Handboek van de pathologie en therapie der krankzinnigheid. Utrecht: FA Hartsen, 1863.
13.Magnan, V. Leçons cliniques, 2nd edn. Paris: Bataille 1893.
14.Tuinier, S. ‘Gaslighting’. Deopkomst van de psychofarmaca ende anti-psychiatrie. In: Geschiedenis, Psychologie, Mentaliteit. Damen, M, Koedijk, P, Pols, F van der, Teilegen, JW, Veltman, E, eds. Amsterdam, Skript 1982; 77100.
15.Praag, HM van. ‘Make-believes’ in psychiatry or the perils of progress. New York: Bunner/Mazel, 1993.
16.Praag, HM van. Voorbij de hoofdstroom: over de wetenschappelijke ankerpunten van een psychiatrische loopbaan. Amsterdam: Balans 1998.
17.Grawe, K. Psychotherapieforschung zu Beginn der neunziger Jahre. Psychologische Rundschau 1992;43;132–62.
18.Bertolote, JM, De Girolama, G. Essential Treatment in Psychiatry, Geneve: WHO 1993.
19.Kadera, SW, Lambert, MJ, Andrews, AA. How much therapy is really enough? J Psychother Pract Res 1996;5;132–51.
20.Cummings, JL, Hegarty, A. Neurology, psychiatry and neuropsychiatry. Neurology 1994;44;209–18.
21.Laborit, J. Huguenard, P, Alluaume, R. Un nouveau stabilisateur végétatif (le 4560 RF). Press Med 1952;60;206–8.
22.Snyder, SH, Banerjee, SP, Yamamura, HI, Greenberg, D. Drugs, neurotransmitters, and schizophrenia. Science 1974; 184: 1243–53.
23.Verhoeven, WMA. Neuropeptides and schizophrenia: a review and critical reappraisal. In: Advances in the Neurobiology of Schizophrenia. Boer, JA den, Westenberg, HGM, Praag, HM van eds. Chichester; John Wiley and Sons, 1995: 303–26.
24.Fekkes, D, Pepplinkhuizen, L. Amino acid studies in transient acute polymorphic psychosis. Amino Acids 1997;12;107–17.
25.Kahn, RS, Praag, HM van. De rol van Serotonine bij schizofrenie. In: Leerboek schizofrenie. Een neurobiologische benadering. den Boer, J.A. en van den Bosch, R.J. (Eds.). De Tijdstroom Utrecht 1996;143–50.
26.Westenberg, HGM, Den Boer, JA. De neurochemische basis voor psychofarmaca; Over dopamine, Serotonine, cholecystekinine en glutamaat. In: Leerboek schizofrenie. Een neurobiologische benadering. Boer, JA den, Bosch, RJ van den, eds. Utrecht: De Tijdstroom, 1996; 109–27.
27.Kuhn, R. Uber die Behandlung depressiver Zustände mit einem Iminodibenzylderivat (G 22355). Schweiz Med Wochenschr 1957; 35/36: 1135–40.
28.Praag, HM van. Faulty cortisol/serotonin interplay. Psychopatho-logical and biological characterisation of a new, hypothetical depression subtype (SeCA depression). Psychiat Res 1996;65;143–57.
29.Verhoeven, WMA, Tuinier, S. Neurotransmitters, hormonen en depressies; theorieën over de Pathogenese. In: Handboek Stem-mingsstoornissen. Boer, JA den, Ormel, J, Praag, HM van, Westenberg, HGM, D'haenen, H, eds. Utrecht: De Tijdstroom, 1999; in press.
30.Parnham, MJ, Bruinvels, J. Discoveries in pharmacology, Volume I. Psycho- and Neuro-pharmacology. Amsterdam-New York: Elsevier, 1983.
31.Praag, HM van, Asnis, GM, Kahn, RS, et al.Nosological tunnel vision in biological psychiatry. A plea for a functional psychopathology, Ann N Y Acad Sci 1990;600;501–10.
32.Praag, HM van, Leijnse, B. Neubewerting des Syndroms. Skizze einer funktionellen Pathologie. Psychiat neurol Neurochir 1965;8;5066.
33.Praag, HM van, Asnis, GM, Brown, SL, et al.Beyond serotonin. A multi-aminergic perspective on abnormal behavior. In: Brown, SL, Praag, HM van, eds. The role of serotonin in psychiatry disorders. New York: Brunner/Mazel, 1991: 302–32.
34.Tuinier, S, Verhoeven, WMA. Neurobiologie van agressie en impulsiviteit. Acta Neuropsychiat 1999;11;510.
35.Verhoeven, WMA, Tuinier, S. Symptomatology and Pathophysiology of Psychotic Disorders in Parkinson's Disease. Eur J Psychiat 1995;46;937.
36.Stuiver, BT, Sebens, JB, Horst, GJ ter, Korf, J. Huidige inzichten in werkingsmechanismen van psychofarmaca. Pharm Weekbl 1994;129;511–6.
37.Northoff, G. Ansätze zu einer Neuropsychiatrie als Uberbrückung der Trennung von Neurologie und Psychiatrie. Schweiz Arch Neurol Psychiatr 1992;143;2738.
38.Cummings, JL. Frontal subcortical circuits and human behaviour. Arch Neurol 1993;50;873–80.
39.Weitzner, MA. Neuropsychiatry and pituitary disease: An overview. Psychother Psychosom 1998;67;125–32.
40.Kloet, ER de. Brain corticosteroid receptor balance and homeostatic control. Front Neuroendocrinol 1991;12;95164.
41.Kloet, ER de. Neurobiologie van adaptatiestoornissen. Acta Neuropsychiat 1999;11;11–4.
42.Leshner, AI. Addicton is a brain disease, and it matters. Science 1997;278;45–7.
43.Saint-Cyr, JA, Taylor, AE, Nicholson, K. Behaviour and the basal ganglia. Adv Neurol 1995;65;128.
44.Verhoeven, WMA, Tuinier, S, Berg, YWMM van den, Coppus, , et al.Stress and self-injurious behaviour; hormonal and serotonergic parameters in mentally retarded subjects. Pharmacopsychiat 1999;32;1320.
45.Verhoeven, WMA, Tuinier, S. Neuropsychiatriche diagnostiek. In: Verhoeven, WMA, Tuinier, S, Curfs, LMG, eds. Diagnostiek en behandeling van gedragsproblemen bij verstandelijk gehandicapten. Cure & Care Development, 1999; in press.
46.Marin, RS. Apathy: A neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 1991;3;243–54.
47.Marin, RS, Fogel, BS, Hawkins, J, Duffey, J, Krupp, B. Apathy: A treatable syndrome. J Neuropsychiat clin Neurosci 1995; 7: 2330.
48.Müller, U, Von Cramon, Y. The therapeutic potential of bromocriptine in neuropsychological rehabilitation of patiens with acquired brain damage. Prog Neuropsychopharmacol Biol Psychiat 1994;18;1103–20.
49.Cummings, JL. Motility, behaviour and the brain. J psychosom Res 1998;44;643–44.
50.Sandman, CA, Hetrick, W, Taylor, DV, Chicz-DeMet, A. Dissociation of POMC peptides after self-injury predicts responses to centrally acting opiate blockers. Am J ment Retard 1997;102;182–99.
51.Tuinier, S, Verhoeven, WMA. Dimensional classification and behavioral pharmacology of personality disorders; a review and hypothesis. Eur Neuropsychopharmacol 1995;5;135–46.
52.Kandel, ER. A new intellectual framework for psychiatry. Am J Psychiatry 1998;155;457–69.
53.Coffey, CD, Cummings, JL, Duffy, JD, et al.Assessment of treatment outcomes in neuropsychiatry: A report from the committee on research of the American Neuropsychiatric Association. J Neuropsychiatr clin Neurosci 1995;7;287–9.
54.Cummings, JL, Coffey, CE, Duffy, JD, et al.The clinician-scientist in neuropsychiatry: A position statement from the committee on research of the American Neuropsychiatric Association. J Neuropsychiat clin Neurosci 1998;10;19.
55.Ministerie van Volksgezondheid, Welzijn en Sport. Beleidsvisie Geestelijke Gezondheidszorg 1999. 's-Gravenhage: Ministerie van VWS, 1998.
56.Verhoeven, WMA, Goessens, LFM, Berg, YWMM van den, Tuinier, S. Integratie van opleiding en onderzoek in de opleiding tot psychiater. Acta Neuropsychiat 1999;11;1823.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed